CORE B ABSTRACT Core B, the Molecular Pathology and Imaging Core (MPIC;formerly the Morphology Core), was established in 1995 and has been a part of this Program Project since its inception. During this time, MPIC has served as a model core facility for numerous other program projects and centers at the University of Pennsylvania and throughout the country. The overarching goal of MPIC is to provide exceptional service and support to the P01 investigators and their laboratories, accomplished through two Specific Aims: 1) To provide essential, cost- effective, and high quality services and support to the esophageal cancer P01 investigators and their laboratories for the preparation, sectioning, staining, and interpretation of tissue sections, both animal and human, as well as cultured cells;and 2) To assist in planning and optimizing (a) in situ hybridization (ISH), immunohistochemistry (IHC), and immunofluorescence (IF) experiments and (b) microscopy and image analyses for the esophageal cancer P01 members and their laboratories and to provide training in these techniques, as well as perform these services as requested. MPIC is lead by an experienced Director (Dr. Jonathan Katz), Technical Director (Mr. Adam Bedenbaugh), and Consultant (Dr. Andres Klein-Szanto). Moreover, MPIC is a unique entity at the University of Pennsylvania and the Dana Farber Cancer Institute and possesses specific expertise in processing and analyses of all tissue types relevant to this P01. MPIC continues to provide essential, routine services, such as tissue processing and staining, as well as advanced technologies, such as spinning-disk confocal microscopy with an environmental chamber for live-cell imaging, to P01 investigators and their lab personnel. MPIC also fosters cost-effective approaches and promotes new and exciting directions for research. In addition, MPIC offers special benefits to members of this P01 that are not available to other users including esophageal cancer specific TMAs, significant subsidies for services, priority services, and access to Dr. Klein-Szanto, an expert clinical pathologist. Since the last submission of this application, we have continued to incorporate and integrate new services and technologies and, reflective of these changes and the services currently provided to our users, have changed the name of the Core from the Morphology Core to the Molecular Pathology and Imaging Core. Recent enhancements include relocation into more than 1000 square feet of newly renovated space, upgrade of a Yokagawa CSU-10 spinning disk confocal microscope for live-cell imaging, integration of an Olympus IX81 live-cell imaging system, and incorporation of on-line scheduling and ordering. Thus, MPIC provides exceptional utility, quality, value, experience, service, and commitment to this P01, and this P01 receives top priority.

Public Health Relevance

Core B, the Molecular Pathology and Imaging Core (MPIC;formerly the Morphology Core), provides a number of key services for P01 investigators and their laboratories including the processing and staining of tissues relevant to this P01, microscopy, and image analysis. Notably, MPIC offers special benefits to members of this P01 that are not available to other users. Overall, MPIC provides exceptional utility, quality, value, experience, service, and commitment to this P01, and this P01 receives top priority.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-RPRB-O (M1))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
United States
Zip Code
Zhou, Jin; Wu, Zhong; Wong, Gabrielle et al. (2017) CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinoma. Nat Commun 8:13897
Whelan, K A; Chandramouleeswaran, P M; Tanaka, K et al. (2017) Autophagy supports generation of cells with high CD44 expression via modulation of oxidative stress and Parkin-mediated mitochondrial clearance. Oncogene 36:4843-4858
Whelan, Kelly A; Merves, Jamie F; Giroux, Veronique et al. (2017) Autophagy mediates epithelial cytoprotection in eosinophilic oesophagitis. Gut 66:1197-1207
Harmeyer, Kayla M; Facompre, Nicole D; Herlyn, Meenhard et al. (2017) JARID1 Histone Demethylases: Emerging Targets in Cancer. Trends Cancer 3:713-725
Facompre, Nicole D; Sahu, Varun; Montone, Kathleen T et al. (2017) Barriers to generating PDX models of HPV-related head and neck cancer. Laryngoscope 127:2777-2783
Yoshioka, Masahiro; Ohashi, Shinya; Ida, Tomomi et al. (2017) Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells. J Exp Clin Cancer Res 36:101
Natsuizaka, Mitsuteru; Whelan, Kelly A; Kagawa, Shingo et al. (2017) Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma. Nat Commun 8:1758
Giroux, VĂ©ronique; Lento, Ashley A; Islam, Mirazul et al. (2017) Long-lived keratin 15+ esophageal progenitor cells contribute to homeostasis and regeneration. J Clin Invest 127:2378-2391
Fichter, Christiane Daniela; Przypadlo, Camilla Maria; Buck, Achim et al. (2017) A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion. J Pathol 243:481-495
Facompre, Nicole D; Harmeyer, Kayla M; Sole, Xavier et al. (2016) JARID1B Enables Transit between Distinct States of the Stem-like Cell Population in Oral Cancers. Cancer Res 76:5538-49

Showing the most recent 10 out of 149 publications